Market Overview

Recap: Amedisys Q2 Earnings


Shares of Amedisys (NASDAQ:AMED) were flat in after-market trading after the company reported Q2 results.

Quarterly Results

Earnings per share were up 10.74% over the past year to $1.34, which beat the estimate of $0.81.

Revenue of $485,059,000 decreased by 1.61% year over year, which beat the estimate of $469,130,000.


The upcoming fiscal year's EPS expected to be between $4.84 and $5.06.

The upcoming fiscal year's revenue expected to be between $2,040,000,000 and $2,070,000,000.

Price Action

52-week high: $221.88

52-week low: $121.00

Price action over last quarter: Up 25.04%

Company Profile

Amedisys Inc is a healthcare services company in the United States. The company brings healthcare to the home through the provision of home healthcare services, hospice services, and personal care services. The Home Health Segment provides skilled nurses, therapists, and aids to patient's homes throughout the United States. The Hospice segment operates many centers designed to provide comfort and support for terminally ill patients. The Personal Care Segment provides individuals with assistance in the daily living activities. A majority of the company's revenue is derived from the Home Health segment. Additionally, the Hospice segment accounts for a substantial amount of revenue, while the Personal Care segment makes up for the small remaining revenue.


Related Articles (AMED)

View Comments and Join the Discussion!

Posted-In: Earnings